container_end_page 175
container_issue 1
container_start_page 173
container_title American journal of kidney diseases
container_volume 66
creator Shotwell, Matthew S., PhD
Madonia, Phillip N., MD
Connor, Michael J., MD
Amde, Milen, MD
Salem, Charbel, MD
Aduroja, Olufemi A., MD
Bauer, Seth R., PharmD
Groszek, Joseph J., BS
Fissell, William H., MD
description
doi_str_mv 10.1053/j.ajkd.2015.03.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1691597824</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0272638615005223</els_id><sourcerecordid>1691597824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</originalsourceid><addsrcrecordid>eNp9kU-P1SAUxYnROM_RL-DCdOmm9QKlpYkxMY06k0zixH9bwgOq9FEYgb74vr00b3ThwgXhBM65ufd3EXqOocHA6Ku5kfNBNwQwa4A2APgB2mFGaN1xyh-iHZCe1B3l3QV6ktIMAAPtusfogrABE97CDsXR3sUwufBLKuur2x8yLlKFg_UmW5Wq8jZGW6R07lRdO1fdymyNz6n6ZJSxR-u_V2PwKiw2S583na1fw5qqb8aHYzlFXpklaCvdKdn0FD2apEvm2f19ib6-f_dlvKpvPn64Ht_e1KrlONeaad7uW6pY37cdnwinrVR7AEUxATYQrDTVmPJpmkjXMyyhJZLgXg8T0-XvEr081y0D_lxNymKxSRnnpDelJ4G7AbOh56QtVnK2qhhSimYSd9EuMp4EBrGxFrPYWIuNtQAqCusSenFff90vRv-N_IFbDK_PBlOmPFoTRVIFnTLaRqOy0MH-v_6bf-LKWb9t4mBOJs1hjb7wE1gkIkB83ra9LRszAEYIpb8BLNOmuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1691597824</pqid></control><display><type>article</type><title>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Shotwell, Matthew S., PhD ; Madonia, Phillip N., MD ; Connor, Michael J., MD ; Amde, Milen, MD ; Salem, Charbel, MD ; Aduroja, Olufemi A., MD ; Bauer, Seth R., PharmD ; Groszek, Joseph J., BS ; Fissell, William H., MD</creator><creatorcontrib>Shotwell, Matthew S., PhD ; Madonia, Phillip N., MD ; Connor, Michael J., MD ; Amde, Milen, MD ; Salem, Charbel, MD ; Aduroja, Olufemi A., MD ; Bauer, Seth R., PharmD ; Groszek, Joseph J., BS ; Fissell, William H., MD</creatorcontrib><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2015.03.001</identifier><identifier>PMID: 25912840</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Anti-Bacterial Agents - blood ; Anti-Bacterial Agents - pharmacokinetics ; Anti-Bacterial Agents - therapeutic use ; Area Under Curve ; Bacterial Infections - drug therapy ; Bacterial Infections - mortality ; Ciprofloxacin - blood ; Ciprofloxacin - pharmacokinetics ; Ciprofloxacin - therapeutic use ; Critical Illness - mortality ; Dose-Response Relationship, Drug ; Drug Resistance, Microbial ; Female ; Humans ; Male ; Metabolic Clearance Rate ; Microbial Sensitivity Tests ; Middle Aged ; Nephrology ; Prospective Studies ; Renal Dialysis - methods</subject><ispartof>American journal of kidney diseases, 2015-07, Vol.66 (1), p.173-175</ispartof><rights>National Kidney Foundation, Inc.</rights><rights>2015 National Kidney Foundation, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</citedby><cites>FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.ajkd.2015.03.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25912840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shotwell, Matthew S., PhD</creatorcontrib><creatorcontrib>Madonia, Phillip N., MD</creatorcontrib><creatorcontrib>Connor, Michael J., MD</creatorcontrib><creatorcontrib>Amde, Milen, MD</creatorcontrib><creatorcontrib>Salem, Charbel, MD</creatorcontrib><creatorcontrib>Aduroja, Olufemi A., MD</creatorcontrib><creatorcontrib>Bauer, Seth R., PharmD</creatorcontrib><creatorcontrib>Groszek, Joseph J., BS</creatorcontrib><creatorcontrib>Fissell, William H., MD</creatorcontrib><title>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><subject>Aged</subject><subject>Anti-Bacterial Agents - blood</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Area Under Curve</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - mortality</subject><subject>Ciprofloxacin - blood</subject><subject>Ciprofloxacin - pharmacokinetics</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Critical Illness - mortality</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Microbial</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Metabolic Clearance Rate</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Prospective Studies</subject><subject>Renal Dialysis - methods</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-P1SAUxYnROM_RL-DCdOmm9QKlpYkxMY06k0zixH9bwgOq9FEYgb74vr00b3ThwgXhBM65ufd3EXqOocHA6Ku5kfNBNwQwa4A2APgB2mFGaN1xyh-iHZCe1B3l3QV6ktIMAAPtusfogrABE97CDsXR3sUwufBLKuur2x8yLlKFg_UmW5Wq8jZGW6R07lRdO1fdymyNz6n6ZJSxR-u_V2PwKiw2S583na1fw5qqb8aHYzlFXpklaCvdKdn0FD2apEvm2f19ib6-f_dlvKpvPn64Ht_e1KrlONeaad7uW6pY37cdnwinrVR7AEUxATYQrDTVmPJpmkjXMyyhJZLgXg8T0-XvEr081y0D_lxNymKxSRnnpDelJ4G7AbOh56QtVnK2qhhSimYSd9EuMp4EBrGxFrPYWIuNtQAqCusSenFff90vRv-N_IFbDK_PBlOmPFoTRVIFnTLaRqOy0MH-v_6bf-LKWb9t4mBOJs1hjb7wE1gkIkB83ra9LRszAEYIpb8BLNOmuA</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Shotwell, Matthew S., PhD</creator><creator>Madonia, Phillip N., MD</creator><creator>Connor, Michael J., MD</creator><creator>Amde, Milen, MD</creator><creator>Salem, Charbel, MD</creator><creator>Aduroja, Olufemi A., MD</creator><creator>Bauer, Seth R., PharmD</creator><creator>Groszek, Joseph J., BS</creator><creator>Fissell, William H., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150701</creationdate><title>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</title><author>Shotwell, Matthew S., PhD ; Madonia, Phillip N., MD ; Connor, Michael J., MD ; Amde, Milen, MD ; Salem, Charbel, MD ; Aduroja, Olufemi A., MD ; Bauer, Seth R., PharmD ; Groszek, Joseph J., BS ; Fissell, William H., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents - blood</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Area Under Curve</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - mortality</topic><topic>Ciprofloxacin - blood</topic><topic>Ciprofloxacin - pharmacokinetics</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Critical Illness - mortality</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Microbial</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Metabolic Clearance Rate</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Prospective Studies</topic><topic>Renal Dialysis - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shotwell, Matthew S., PhD</creatorcontrib><creatorcontrib>Madonia, Phillip N., MD</creatorcontrib><creatorcontrib>Connor, Michael J., MD</creatorcontrib><creatorcontrib>Amde, Milen, MD</creatorcontrib><creatorcontrib>Salem, Charbel, MD</creatorcontrib><creatorcontrib>Aduroja, Olufemi A., MD</creatorcontrib><creatorcontrib>Bauer, Seth R., PharmD</creatorcontrib><creatorcontrib>Groszek, Joseph J., BS</creatorcontrib><creatorcontrib>Fissell, William H., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shotwell, Matthew S., PhD</au><au>Madonia, Phillip N., MD</au><au>Connor, Michael J., MD</au><au>Amde, Milen, MD</au><au>Salem, Charbel, MD</au><au>Aduroja, Olufemi A., MD</au><au>Bauer, Seth R., PharmD</au><au>Groszek, Joseph J., BS</au><au>Fissell, William H., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>66</volume><issue>1</issue><spage>173</spage><epage>175</epage><pages>173-175</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25912840</pmid><doi>10.1053/j.ajkd.2015.03.001</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-6386
ispartof American journal of kidney diseases, 2015-07, Vol.66 (1), p.173-175
issn 0272-6386
1523-6838
language eng
recordid cdi_proquest_miscellaneous_1691597824
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Aged
Anti-Bacterial Agents - blood
Anti-Bacterial Agents - pharmacokinetics
Anti-Bacterial Agents - therapeutic use
Area Under Curve
Bacterial Infections - drug therapy
Bacterial Infections - mortality
Ciprofloxacin - blood
Ciprofloxacin - pharmacokinetics
Ciprofloxacin - therapeutic use
Critical Illness - mortality
Dose-Response Relationship, Drug
Drug Resistance, Microbial
Female
Humans
Male
Metabolic Clearance Rate
Microbial Sensitivity Tests
Middle Aged
Nephrology
Prospective Studies
Renal Dialysis - methods
title Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A00%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ciprofloxacin%20Pharmacokinetics%20in%20Critically%20Ill%20Patients%20Receiving%20Concomitant%20Continuous%20Venovenous%20Hemodialysis&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Shotwell,%20Matthew%20S.,%20PhD&rft.date=2015-07-01&rft.volume=66&rft.issue=1&rft.spage=173&rft.epage=175&rft.pages=173-175&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2015.03.001&rft_dat=%3Cproquest_cross%3E1691597824%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1691597824&rft_id=info:pmid/25912840&rft_els_id=1_s2_0_S0272638615005223&rfr_iscdi=true